LUMIPHORE, INC.
A theranostic chelator-minibody conjugate (Lumi804-based) that binds Zr-89 for PET imaging and Lu-177 or Th-227 for targeted radionuclide therapy of cancer
- Sector
- Biotech
- Total capital
- $252K
- Federal grants
- $252K
- 1 award · 2021
- Rank in peer group#210 of 392
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 16 pending · first 2018
- Rank in peer group#14 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Single Chelator-Minibody Conjugate for PET and Therapy Radionuclides$252K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#14 · top 4%
- Linked publications#11 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 9 granted of 25- New patentMacrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofUSPTOUS 12,767,657
- GrantedMacrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofUSPTOUS 12,440,584
- PendingHydroxamic Acid Macrocyclic Agents With Pendant Chelating Moieties And Complexes ThereofUSPTOApplication 18834195
Show all 25 patent records
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofOct 20, 2026 · US 12,767,657Granted
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofOct 14, 2025 · US 12,440,584Granted
- Hydroxamic Acid Macrocyclic Agents With Pendant Chelating Moieties And Complexes ThereofMay 29, 2025 · Application 18834195Pending
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApr 9, 2024 · US 11,951,188Granted
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofFeb 29, 2024 · Application 18182147Pending
- Thiohydroxypyridine ChelatesFeb 22, 2024 · Application 18250096Pending
- MacrocyclesJul 4, 2023 · US 11,691,997Granted
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofMar 14, 2023 · US 11,603,371Granted
- Macrocycle ConjugatesSep 23, 2021 · Application 17253550Pending
- Radiopharmaceutical ComplexesJan 23, 2020 · Application 16241507Pending
- Functionalized Linear Ligands And Complexes ThereofOct 8, 2019 · US 10,434,186Granted
- Kit And Method For Detecting Or Quantifying One Or Multiple Nucleic Acid TargetsOct 3, 2019 · Application 16303388Pending
- MacrocyclesApr 30, 2019 · US 10,273,256Granted
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofMar 26, 2019 · US 10,239,878Granted
- Multiplexed Homogeneous Oligonucleotide DetectionMar 13, 2018 · US 9,914,959Granted
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApplication PCTUS2017050118Pending
- Hydroxamic Acid Macrocyclic Agents With Pendant Chelating Moieties And Complexes ThereofApplication PCTUS2023061735Pending
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApplication 62383205Pending
- Macrocycle ConjugatesApplication PCTUS2019038057Pending
- Thiohydroxypyridine ChelatesApplication 63094752Pending
- Hydroxamic Acid Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApplication 63305501Pending
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApplication PCTUS2019021229Pending
- Macrocycle ConjugatesApplication 62686997Pending
- Radiopharmaceutical ComplexesApplication 15978881Pending
- Macrocyclic Ligands With Pendant Chelating Moieties And Complexes ThereofApplication 62639939Pending
Recent research by its founders
- Matched pair suitability of 89Zr and 177Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanoma20251 cites
- Development of L804-based Radiopharmaceuticals for Melanoma: A tale of 177Lu and 161Tb20250 cites
- Evaluating 177Lu-radiolabeled tracers for targeting melanoma tumors utilizing dansyl-L-phenylalanine as a novel albumin binder20250 cites
Related companies, and why
- 42Bio, LLCSimilar federal contract value in Biotech · null in contracts
- SUNTHETICS, INC.Similar federal contract value in Biotech · null in contracts
- ABTELUM BIOMEDICAL, INC.Similar federal contract value in Biotech · null in contracts
- ARES IMMUNOTHERAPY, INC.Similar federal contract value in Biotech · null in contracts
- LIPO-IMMUNO TECH, LLCSimilar federal contract value in Biotech · null in contracts
- SCYNEXIS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .